A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
Condition:   2019-nCoV Pneumonia Interventions:   Drug: ASC09F+Oseltamivir;   Drug: Ritonavir+Oseltamivir;   Drug: Oseltamivir Sponsor:   Tongji Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2020 Category: Research Source Type: clinical trials